ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Adult Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,839Medicare Part D Prescriptions Filled, Including Refills

Rank: 26 out of 129

$727K Total Retail Price of All Prescriptions

Rank: 12 out of 129

395 Patients Receiving at Least One Drug in Part D
87%Patients 65 Years and Older
93% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Florida
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

8% of this provider’s 395 patients filled at least one prescription for a schedule three drug, compared to an average of 8%.

Risky Drugs to Seniors

2% of this provider’s 10,071 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

35% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$67 was the average price of a prescription from this provider, compared to $51 among peers.

Prescriptions per Patient

27 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Florida
OMEPRAZOLE 325 291 1 2
SIMVASTATIN 256 253 2 1
LEVOTHYROXINE SODIUM 241 228 3 5
KETOCONAZOLE 223 208 4 101
LISINOPRIL 221 216 5 3
AMLODIPINE BESYLATE 200 186 6 4
NEXIUM 178 151 7 40
METOPROLOL TARTRATE 176 166 8 7
TRAMADOL HCL 156 129 9 24
DIOVAN 156 151 9 41
CLONIDINE HCL 150 135 11 49
ZOLPIDEM TARTRATE 145 139 12 14
ENALAPRIL MALEATE 143 126 13 34
VOLTAREN 143 143 13 68
ATENOLOL 139 134 15 10
LOVAZA 137 114 16 90
METFORMIN HCL 135 121 17 6
CLOPIDOGREL 131 131 18 23
CARVEDILOL 129 127 19 18
CRESTOR 128 122 20 15
FUROSEMIDE 127 127 21 8
NAMENDA 126 126 22 48
SPIRONOLACTONE 125 112 23 80
PLAVIX 121 121 24 36
ATORVASTATIN CALCIUM 120 114 25 22
LIDODERM 113 107 26 91
LOSARTAN POTASSIUM 110 97 27 12
QUETIAPINE FUMARATE 108 105 28 81
LANTUS 107 89 29 59
IBUPROFEN 106 90 30 30
ESCITALOPRAM OXALATE 95 94 31 68
GABAPENTIN 95 90 31 16
DONEPEZIL HCL 95 95 31 29
CITALOPRAM HBR 90 90 34 27
RANITIDINE HCL 90 84 34 25
INSULIN SYRINGE 89 76 36 70
FLUTICASONE PROPIONATE 89 80 36 33
DIGOXIN 89 89 36 47
MUPIROCIN 88 86 39 95
SURE COMFORT 87 86 40 127
PANTOPRAZOLE SODIUM 87 73 40 44
MEGESTROL ACETATE 85 85 R 42 86
POTASSIUM CHLORIDE 84 84 43 26
PAROXETINE HCL 76 71 44 56
ADVAIR DISKUS 76 75 44 46
LANTUS SOLOSTAR 75 66 46 163
METOPROLOL SUCCINATE 75 75 46 17
MECLIZINE HCL 72 71 48 75
LYRICA 69 65 49 131
FAMOTIDINE 66 62 50 60
AZITHROMYCIN 65 52 51 35
PREDNISONE 65 63 51 54
PEN NEEDLE 63 52 53 240
HYDROCODONE-ACETAMINOPHEN 63 45 S3 53 20
SEROQUEL 63 63 53 154
SSD 62 62 56 173
LANSOPRAZOLE 61 55 57 111
DEXILANT 58 57 58 192
GEMFIBROZIL 56 56 59 88
NOVOLOG FLEXPEN 55 45 60 218
RISPERIDONE 55 55 60 93
DOXAZOSIN MESYLATE 53 39 62 58
BUMETANIDE 52 43 63 123
ALENDRONATE SODIUM 52 52 63 13
SINGULAIR 51 46 65 67
EXELON 51 51 65 146
DICLOFENAC SODIUM 50 50 67 65
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 9, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.